NCT01290835

Conformal Partial Breast Irradiation With CyberKnife After Resection for Early Stage Breast Cancer

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: Essentia Health · Academic / Other
• Sex: Female
• Age: 60 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine if it is feasible, safe, and effective to use Cyberknife radiotherapy to deliver partial breast radiotherapy after lumpectomy.Patients meeting eligibility criteria will be invited to participate. Adjuvant radiotherapy will be delivered using CyberKnife radiotherapy using twice daily sessions for five days for a total of ten sessions. Short-term and long-term toxicity will be assessed as well as Tumor control and site of failure (if any).

Detailed description

This study will determine the feasibility and toxicity of a short course of accelerated radiotherapy as adjuvant treatment for early stage breast cancer. Successful completion of this project may provide a rationale to offer this treatment for select patients with the benefit of potentially less tissue damage and a shorter overall course of therapy. These improvements may ultimately allow more patients the opportunity of breast conserving therapy to treat their cancer

Conditions

• Breast Cancer

Interventions

Type	Name	Description
RADIATION	Stereotactic radiotherapy delivered by CyberKnife	Adjuvant radiotherapy will be delivered using CyberKnife radiotherapy using twice daily sessions for five days for a total of ten sessions.
RADIATION	stereotactic radiotherapy

Timeline

• Start date: 2010-06-01
• Primary completion: 2025-08-01
• Completion: 2025-08-01
• First posted: 2011-02-07
• Last updated: 2025-08-15

Locations

1 site across 1 country: United States